EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

PEGylated Chitosan Nanoparticles: Engineering Multifunctional Platforms for Targeted Cervical and Lung Cancer Treatment

Prashant Kesharwani iD, Nazim Nasir, Shadma Wahab, Garima Gupta, Khang Wen Goh, Amirhossein Sahebkar iD

Cancer Science · 2026

DOI: 10.1111/cas.70361 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Science, 2026. Verfasst von Prashant Kesharwani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Next-Generation Translational Nanomedicine Laboratory, Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya (A Central Universit…. Hauptthemen laut MEDLINE: Chitosan, Polyethylene Glycols, Nanoparticles, Lung Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Deanship of Research and Graduate Studies at King Khalid University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polymer‐based nanocarriers have emerged as transformative platforms in cancer nanomedicine, enabling controlled and site‐specific delivery of therapeutic agents. Among polysaccharide‐derived materials, chitosan stands out for its biodegradability, biocompatibility, and intrinsic mucoadhesive properties that promote efficient drug encapsulation and enhanced cellular internalization. Surface PEGylation the conjugation of polyethylene glycol (PEG) chains further augments the physicochemical and biological performance of chitosan nanoparticles by enhancing colloidal stability, extending systemic circulation, and reducing opsonization by the reticuloendothelial system. In addition, ligand‐mediated functionalization facilitates active tumor targeting and selective intracellular delivery, thereby improving therapeutic efficacy while minimizing off‐target toxicity. This review critically summarizes recent advances in the design, synthesis, and functional modification of PEGylated chitosan nanoparticles, with emphasis on their pharmacokinetic behavior, drug release mechanisms, and anticancer performance. Comparative insights into other polymeric and lipid‐based nanocarrier systems are also provided. Finally, current challenges, safety considerations, and translational perspectives are discussed, underscoring the promise of PEGylated chitosan nanoplatforms as next‐generation biomaterials for precision oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChitosanPolyethylene GlycolsNanoparticlesLung NeoplasmsUterine Cervical NeoplasmsAntineoplastic AgentsHumansAnimalsFemaleDrug CarriersDrug Delivery SystemsNanomedicine

Stichwörter der Autor:innen

PEGylated chitosan nanoparticlesbiopolymer modificationcancer nanomedicineclinical translationcontrolled releasetargeted drug deliverytumor targeting

Substanzen

ChitosanPolyethylene GlycolsAntineoplastic AgentsDrug Carriers

Autor:innen und Institutionen

  • Next-Generation Translational Nanomedicine Laboratory, Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya (A Central University), Sagar, Madhya Pradesh, India.
  • Department of Research and Development, Asia University, Taichung, Taiwan.
  • University Institute of Pharma Sciences, Chandigarh University, Mohali, Punjab, India.
  • Department of Basic Medical Sciences, College of Applied Medical Sciences, Khamis Mushait, King Khalid University, Abha, Saudi Arabia.
  • Department of Pharmacognosy, College of Pharmacy, King Khalid University, Abha, Saudi Arabia.
  • Graphic Era Hill University, Dehradun, India.

ORCID-Profile: Prashant Kesharwani, Amirhossein Sahebkar

Förderung

  • Deanship of Research and Graduate Studies at King Khalid University

Zitieren

APA

Kesharwani, P., Nasir, N., Wahab, S., Gupta, G., Goh, K. W., & Sahebkar, A. (2026). PEGylated Chitosan Nanoparticles: Engineering Multifunctional Platforms for Targeted Cervical and Lung Cancer Treatment. Cancer Science. https://doi.org/10.1111/cas.70361

Vancouver

Kesharwani P, Nasir N, Wahab S, Gupta G, Goh KW, Sahebkar A. PEGylated Chitosan Nanoparticles: Engineering Multifunctional Platforms for Targeted Cervical and Lung Cancer Treatment. Cancer Science. 2026. doi:10.1111/cas.70361

BibTeX
@article{Kesharwani2026,
  author = {Kesharwani, Prashant and Nasir, Nazim and Wahab, Shadma and Gupta, Garima and Goh, Khang Wen and Sahebkar, Amirhossein},
  title = {PEGylated Chitosan Nanoparticles: Engineering Multifunctional Platforms for Targeted Cervical and Lung Cancer Treatment},
  journal = {Cancer Science},
  year = {2026},
  doi = {10.1111/cas.70361}
}
Kostenlos starten →